Moderate dose radiotherapy effective in EORTC trial for patients with desmoid-type fibromatosis

(European Organisation for Research and Treatment of Cancer) A phase 2 EORTC trial for patients with inoperable desmoid-type fibromatosis has shown that moderate dose radiotherapy is an effective treatment for patients with such a rare type of tumor. The study results published in Annals of Oncology show that response after radiation therapy is slow, and that continuing regression is seen even after three years.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news